Science Explorer Back to mapMap
Discussion
Researcher · Scripps Research Institute · United States

Devin Sok

Devin Sok publishes mostly in Virology, Immunology and Infectious Diseases, on topics such as HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research and Immune Cell Function and Interaction.

ORCID 0000-0002-9354-1740 OpenAlex
World rank
#12,933
of 7,710,434 ranked researchers
Rank in United States
#4,507
of 1,627,098
Works
158
Citations
15k
Citations per work
93.5
h-index
59
i10-index 93Top 3.8% in Virology
Devin Sok

What does Devin Sok research?

Devin Sok's work is mostly in Immunology and Microbiology (41%), Medicine (32%), Biochemistry, Genetics and Molecular Biology (15%).

Life Sciences: 88 works · 55.7% of their workImmunology and Microbiology: 65 works · 40.9% of their workVirology: 36 works · 22.7% of their workImmunology: 29 works · 18.2% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 14.8% of their workMolecular Biology: 23 works · 14.8% of their workHealth Sciences: 51 works · 32.4% of their workMedicine: 51 works · 32.4% of their workInfectious Diseases: 25 works · 16.0% of their workRadiology, Nuclear Medicine and Imaging: 16 works · 10.3% of their workEpidemiology: 10 works · 6.1% of their workEverything else: 19 works · 11.9% of their workTHEIR WORKDevin Sok158works
Life Sciences56%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology6540.9%
    2. Biochemistry, Genetics and Molecular Biology2314.8%
    1. Medicine5132.4%
  3. Everything else1911.9%
  1. 1Virology23% of their works
  2. 2Immunology18% of their works
  3. 3Infectious Diseases16% of their works
  4. 4Molecular Biology15% of their works
  5. 5Radiology, Nuclear Medicine and Imaging10% of their works
  6. 6Epidemiology6% of their works

Research topics

Which keywords describe Devin Sok's research?

The keywords of their largest research topics: Antiretroviral Therapy, Vaccine, AIDS, HIV, Fc Receptors, Therapeutic Antibodies, Antigen Presentation and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Antiretroviral Therapy1222 topics
  2. Vaccine1192 topics
  3. AIDS1011 topic
  4. HIV1011 topic
  5. Fc Receptors461 topic
  6. Therapeutic Antibodies461 topic
  7. Antigen Presentation432 topics
  8. Immunity382 topics
  9. NK Cell Recognition321 topic
  10. Natural Killer Cells321 topic
  11. Foxp3251 topic
  12. TGF-ß251 topic
  13. Epitope Prediction231 topic
  14. Peptide-MHC Binding231 topic
  15. Drug Resistance211 topic
  16. HIV Infection211 topic
  17. Cancer Immunotherapy201 topic
  18. Dendritic Cells201 topic
  19. Coronavirus181 topic
  20. SARS-CoV-2181 topic

Where does Devin Sok work?

Devin Sok's main affiliation in the publication record is Scripps Research Institute, United States.

How many publications and citations does Devin Sok have?

OpenAlex counts 158 works and 14,780 citations for Devin Sok, an h-index of 59, ranking #12,933 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Devin Sok. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.